These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33298744)

  • 1. Intravenous Infusion of Fentanyl Has No Effect on Blood Concentration of Tacrolimus in Patients Receiving Hematopoietic Stem-Cell Transplantation.
    Ishiwata Y; Nagata M; Kiuchi S; Ippongi C; Takeda H; Takahashi H
    Ther Drug Monit; 2021 Oct; 43(5):688-691. PubMed ID: 33298744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
    Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
    J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Kitazawa F; Fuchida SI; Kado Y; Ueda K; Kokufu T; Okano A; Hatsuse M; Murakami S; Nakayama Y; Takara K; Shimazaki C
    Ann Transplant; 2017 Sep; 22():575-580. PubMed ID: 28947731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus blood concentration increase depends on administration route when combined with voriconazole in pediatric stem cell transplant recipients.
    Utano T; Kato M; Osumi T; Shioda Y; Kiyotani C; Terashima K; Tomizawa D; Matsumoto K; Yamatani A
    Pediatr Transplant; 2020 Feb; 24(1):e13619. PubMed ID: 31820535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.
    Yamashita T; Fujishima N; Miura M; Niioka T; Abumiya M; Shinohara Y; Ubukawa K; Nara M; Fujishima M; Kameoka Y; Tagawa H; Hirokawa M; Takahashi N
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):111-8. PubMed ID: 27217047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study.
    Hikasa S; Shimabukuro S; Osugi Y; Ikegame K; Kaida K; Fukunaga K; Higami T; Tada M; Tanaka K; Yanai M; Kimura T
    Int J Med Sci; 2020; 17(7):859-864. PubMed ID: 32308538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Genetic Polymorphism of CYP3A5 and CYP2C19 and Concomitant Use of Voriconazole on Blood Tacrolimus Concentration in Patients Receiving Hematopoietic Stem Cell Transplantation.
    Iwamoto T; Monma F; Fujieda A; Nakatani K; Gayle AA; Nobori T; Katayama N; Okuda M
    Ther Drug Monit; 2015 Oct; 37(5):581-8. PubMed ID: 25565672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis.
    Shinogi Y; Hirai T; Ishibashi M; Ino K; Tawara I; Iwamoto T
    Pharmacol Res Perspect; 2023 Aug; 11(4):e01120. PubMed ID: 37530504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus clearance is age-dependent within the pediatric population.
    Przepiorka D; Blamble D; Hilsenbeck S; Danielson M; Krance R; Chan KW
    Bone Marrow Transplant; 2000 Sep; 26(6):601-5. PubMed ID: 11041564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study.
    Ishiwata Y; Nagata M; Arai T; Makiishi M; Yoshikawa M; Takahashi H; Kohsaka H; Yasuhara M
    Ther Drug Monit; 2016 Dec; 38(6):717-721. PubMed ID: 27559841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation.
    Yano S; Mori S; Saito T; Yokoyama H; Machishima T; Shimada T; Yahagi Y; Sugiyama K; Ogasawara Y; Takahara S; Kasama K; Katsube A; Kamiyama Y; Suzuki K; Inui Y; Usui N; Aiba K; Yamashita T
    Ann Hematol; 2015 Mar; 94(3):491-6. PubMed ID: 25325985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic drug interaction between tacrolimus and lansoprazole in a bone marrow transplant patient receiving voriconazole and harboring CYP2C19 and CYP3A5 heterozygous mutations.
    Iwamoto T; Monma F; Fujieda A; Nakatani K; Katayama N; Okuda M
    Clin Ther; 2011 Aug; 33(8):1077-80. PubMed ID: 21802143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simultaneous d-optimal designed study for population pharmacokinetic analyses of mycophenolic Acid and tacrolimus early after renal transplantation.
    Musuamba FT; Mourad M; Haufroid V; Demeyer M; Capron A; Delattre IK; Delaruelle F; Wallemacq P; Verbeeck RK
    J Clin Pharmacol; 2012 Dec; 52(12):1833-43. PubMed ID: 22207766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts.
    Yoshida S; Fujimoto A; Fukushima K; Ando M; Irie K; Hirano T; Miyasaka M; Shimomura Y; Ishikawa T; Ikesue H; Muroi N; Hashida T; Sugioka N
    J Clin Pharm Ther; 2021 Feb; 46(1):190-197. PubMed ID: 33090593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients.
    Baldan N; Rigotti P; Furian L; Margani G; Ekser B; Frison L; De Martin S; Palatini P
    Pharmacol Res; 2006 Sep; 54(3):181-5. PubMed ID: 16750634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungal.
    Nakashima T; Inamoto Y; Aoki J; Ito A; Tanaka T; Kim SW; Hashimoto H; Fukuda T; Furukawa T
    Int J Hematol; 2022 Feb; 115(2):158-162. PubMed ID: 35088349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation.
    Collins J; Shea K; Parsad S; Plach K; Lee P
    J Oncol Pharm Pract; 2020 Jan; 26(1):5-12. PubMed ID: 30854922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of Wuzhi Capsule on tacrolimus blood concentrations in liver transplant patients with different donor-recipient CYP3A5 genotypes.
    Kou K; Sun X; Li M; Li T; Hu Y; Li S; Lv G
    J Clin Pharm Ther; 2022 Feb; 47(2):200-210. PubMed ID: 34708436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
    Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
    J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
    Peksa GD; Schultz K; Fung HC
    J Oncol Pharm Pract; 2015 Dec; 21(6):409-15. PubMed ID: 24938293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.